Travis Klingler, MD
Obstetrics & Gynecology · Laramie, WYNPI 1679560387
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $761 of the $941 with a category attached, or 80.9%. 15 manufacturers reported payments, led by AbbVie at 58.2% of the total. Reporting peaked in 2024 at $393 and has fallen 83.7% since, to $64 in 2025.
Across 48 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$547
- Coloplast$101
- Bayer$51
- Exact Sciences$38
- Hologic Sales And Service, LLC$33
- Biogen$30
- plus $140 from 9 others
What the payments were for
- Speaking & faculty fees$16317%
- Food & beverage$76181%
- Education$162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $547 |
| Coloplast | 4 | $101 |
| Bayer | 3 | $51 |
| Exact Sciences | 2 | $38 |
| Hologic Sales And Service, LLC | 2 | $33 |
| Biogen | 1 | $30 |
| Pfizer | 1 | $22 |
| Myovant Sciences Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Olympus America Inc. | 1 | $15 |
| Roche Diagnostics Corporation | 1 | $15 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$941 in reported general payments places this provider in the 70th percentile of 58 obstetrics & gynecology providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 12 | $5,659 |
| Estradiol | 57 | $4,407 |
| ProgesteroneProgesterone, Micronized | 33 | $1,096 |
| Liothyronine Sodium | 12 | $384 |
| Levothyroxine Sodium | 42 | $207 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $0 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Laramie
- Kim WestbrookLaramie$136
- Jaycee KlineLaramie$0
- Samantha MichelenaCheyenne$15K
- Lindsay CapronSheridan$9K
- Roger BrecheenJackson$8K
- Shannon RobertsJackson$7K
- Michael NelsonCheyenne$7K
- Samer KattanRock Springs$7K
- Melissa HiebCasper$7K
- Camille Mellijor-FiggJackson$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.